Advertisement

Topics

Bristol-Myers Squibb plans 58 layoffs as drug patents expire

14:28 EDT 8 Aug 2017 | Topix

LAWRENCE -- Drugmaker Bristol-Myers Squibb Co. plans to lay off 58 workers as it prepares to lose its patent exclusivity on the HIV drugs Sustiva and Reyataz at the end of the year.

Original Article: Bristol-Myers Squibb plans 58 layoffs as drug patents expire

NEXT ARTICLE

More From BioPortfolio on "Bristol-Myers Squibb plans 58 layoffs as drug patents expire"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...